Provencio M, Nadal E, Insa A, et al. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial. Lancet Oncol 2024; 25: 1453–64—In figure 3 of this Article, the red and blue lines in the key and the numbers at risk and numbers censored, for both part A and part B, were inverted. These corrections have been made to the online version as of Oct 28, 2024, and the printed version is correct.
. 2024 Nov;25(11):e542. doi: 10.1016/S1470-2045(24)00593-X
Correction to Lancet Oncol 2024; 25: 1453–64
© 2024 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC11601650 PMID: 39481412
This corrects the article "Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial" on page 1453.